Friday, 20 Jul 2018

You are here

Pregnancy Flares in RA and Spondylitis

Despite the folklore, not all women with arthritis who become pregnant will improve or go into remission.  Recent studies have suggested that up to one-third of RA patients will flare during pregnancy.

This issue has been further examined in a cohort of 136 pregnant patients with RA and axial spondyloarthritis (axSpA) who were prospectively followed before, during, and after pregnancy.

During pregnancy flares occurred in 29% of RA patients and in 25% of SpA patients.

In RA patients, 15/75 discontinued their tumor necrosis factor inhibitor (TNFi) at the time of a positive pregnancy test, with a nearly 3 fold increased the risk for flare (RR 3.33 (95% CI 1.8-6.1).

Flares were managed with either TNFi or glucocorticosteroid (GC) treatment and yielded improvement in 60%.

Of 61 patients with axSpA, 24 patients were on TNFi and discontinued the treatment at the time of the positive pregnancy test. In axSpA stopping TNFi, also increased the risk of flare (RR 3.08 (95% CI 1.2-7.9).

Patients with axSpA without TNFi in the preconception period showed persistent high disease activity from prepregnancy until the postpartum period.

These data speak to the need for ongoing TNFi therapy in a subset of patients with RA and axSpA beyond conception.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Predictors of Methotrexate Non-Response

New research from a UK study suggests that nonresponse to oral or subcutaneous MTX was seen in 43% and is predicted by seronegativity, higher disease activity measures and higher anxiety scores.

Best of 2017: New EULAR Guidelines on Behçet's

At the EULAR 2016 meeting, new EULAR recommendations for the management of Behçet's disease (BD) were presented. These were developed by a multidisciplinary expert committee that reviewed the evidence from the medical literature and developed final set of 9 recommendations:

EULAR 2018 - Day 3 Report

Day 3 highlights include Behcet’s responds to apremilast and that biologics do not differentially affect TKR/THR post-operative infection rates. Be sure to check out today's podcast as well. 

Canada Closer to Marijuana Approval

Reuters reports that Canada’s Senate on Thursday voted to legalize recreational marijuana, clearing a major hurdle that puts the country on track to become the first Group of Seven nation to permit national use of the drug.

Now the law and amendments go to the House of Commons who will need to decide on before the law can be passed.

Advance Practice Clinicians Proliferating in Specialty Practices

An analysis of SK&A outpatient provider files, covering 90% of physician practices in the United States, shows that between 2008 to 2016, there was a 22% increase in the employment of advanced practice clinicians (APCs) by specialty practices.  By 2016, 28% of all specialty practices employed APCs.